Evidence of polyclonal hematopoiesis in a large proportion of patients with low-risk myelodysplastic syndrome.

被引：0
作者：
Malcovati, L
Della Porta, MG
Galli, A
Boggi, S
Malabarba, L
Pietra, D
Passamonti, F
Bergamaschi, G
Lazzarino, M
Cazzola, M
机构：
[1] Univ Pavia, Div Hematol, Sch Med, I-27100 Pavia, Italy
[2] Policlin San Matteo, IRCCS, I-27100 Pavia, Italy
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2364
引用
收藏
页码：649A / 650A
页数：2
相关论文
共 50 条
  • [31] Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification
    Kontandreopoulou, Christina-Nefeli
    Syriopoulou, Stavroula
    Diamantopoulos, Panagiotis T.
    Giannakopoulou, Nefeli
    Vlachopoulou, Dimitra
    Katsiampoura, Panagiota
    Stafylidis, Christos
    Dimou, Maria
    Galanopoulos, Athanasios
    Papageorgiou, Sotirios
    Hatzimichael, Eleftheria
    Pappa, Vassiliki
    Ioannis, Kotsianidis
    Symeonidis, Argiris
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    [J]. BLOOD, 2022, 140 : 6958 - 6959
  • [32] Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome
    List, AF
    Brasfield, F
    Heaton, R
    GlinsmannGibson, B
    Crook, L
    Taetle, R
    Capizzi, R
    [J]. BLOOD, 1997, 90 (09) : 3364 - 3369
  • [33] Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
    Remacha, Angel F.
    Arrizabalaga, Beatriz
    Villegas, Ana
    Soledad Duran, Maria
    Hermosin, Lourdes
    de Paz, Raquel
    Garcia, Marta
    Diez Campelo, Maria
    Sanz, Guillermo
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (05) : 779 - 787
  • [34] Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
    Ángel F. Remacha
    Beatriz Arrizabalaga
    Ana Villegas
    María Soledad Durán
    Lourdes Hermosín
    Raquel de Paz
    Marta Garcia
    Maria Diez Campelo
    Guillermo Sanz
    [J]. Annals of Hematology, 2015, 94 : 779 - 787
  • [35] SEVERE INFECTION IN LOW RISK MYELODYSPLASTIC SYNDROME. SPONDYLODISCITIS: AN EMERGENT INFECTIVE COMPLICATION?
    Faglioni, L.
    Ferretti, G.
    Anaclerico, B.
    Borza, P. Anticoli
    Bongarzoni, V.
    Bruno, R.
    Cedrone, M.
    Chierichini, A.
    Piccioni, A. L.
    Cortese, S.
    Leonetti, S. Crescenzi
    Ronci, B.
    Monardo, F.
    Pauselli, F.
    Tarasi, A.
    Bagnato, A.
    Fenu, S.
    [J]. HAEMATOLOGICA, 2017, 102 : 156 - 156
  • [36] Imetelstat: a promising solution for transfusion independence in patients with low-risk myelodysplastic syndrome ineligible for current therapies
    Leroyer, Esther Hazane
    [J]. HEMATOLOGIE, 2024, 30 (01): : 10 - 13
  • [37] THE ROLE OF P53 MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY IN PROGNOSIS OF LOW-RISK MYELODYSPLASTIC SYNDROME PATIENTS
    Duarte, F.
    Lemes, R. P. G.
    Barbosa, M. C.
    Vasconcelos, J. P.
    Rocha, F. D.
    dos Santos, T. E. J.
    Zalcberg, I.
    Coutinho, D. F.
    Vasconcelos, P. R. L.
    [J]. LEUKEMIA RESEARCH, 2017, 55 : S139 - S139
  • [38] A MULTICENTRIC PROSPECTIVE PILOT STUDY ON FERROPTOSIS BIOMARKERS IN LOW-RISK MYELODYSPLASTIC SYNDROME
    D'avino, C.
    Pantaleo, A.
    Tsamesidis, I.
    Pilo, F.
    Reybier, K.
    Manca, A.
    Greco, M.
    Fozza, C.
    [J]. HAEMATOLOGICA, 2022, 107 : 63 - 64
  • [39] Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine
    Daitoku, Shinya
    Aoyagi, Tomomi
    Takao, Shinichiro
    Tada, Seiya
    Kuroiwa, Mika
    [J]. INTERNAL MEDICINE, 2018, 57 (20) : 2995 - 2999
  • [40] Treatment of Low-Risk Myelodysplastic Syndrome: Hematopoietic Growth Factors Erythropoietins and Thrombopoietins
    Santini, Valeria
    [J]. SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 295 - 303
12345